Insiders Jazz Pharmaceuticals plc Sao Paulo

Equities

Market Closed - Sao Paulo Other stock markets 09:17:51 2024-05-10 EDT			5-day change	1st Jan Change
38.72 ^BRL	-0.56%		-.--%	-10.95%

06-20	Needham Adjusts Price Target on Jazz Pharmaceuticals to $210 From $222, Maintains Buy Rating	MT
06-20	Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	MT

Jazz Pharmaceuticals plc Announces Catherine Sohn, Pharm.D. Will Not Stand for Re-Election to the Board	05-31	CI
Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing	05-07	MT
Jazz Pharmaceuticals Announces Board Changes	02-27	CI
Jazz Pharmaceuticals Names Philip Johnson as Chief Financial Officer	02-21	MT
Jazz Pharmaceuticals plc Appoints Philip Johnson as Executive Vice President, Effective March 1, 2024	02-21	CI
Kim Sablich to Departure as Executive Vice President and General Manager, US of Jazz Pharmaceuticals plc on December 31, 2023	12-15	CI
Jazz Pharmaceuticals President, COO Dan Swisher to Retire; Renee Gala Named Successor	23-09-12	MT
Jazz Pharmaceuticals plc Announces Management Changes	23-09-11	CI
Insider Sell: Jazz Pharmaceuticals	23-08-17	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Oxford Cannabinoid Technologies Hires Chief Medical Officer	23-06-08	MT
Insider Sell: Jazz Pharmaceuticals	22-12-22	MT
Insider Sell: Jazz Pharmaceuticals	22-12-13	MT
Insider Sell: Jazz Pharmaceuticals	22-12-05	MT
Insider Sell: Jazz Pharmaceuticals	22-11-28	MT
Insider Sell: Jazz Pharmaceuticals	22-11-18	MT

No results for this search